About 535 results

ALLMedicine™ Myeloid Sarcoma Center

Research & Reviews  209 results

Unusual presentations of central nervous system myeloid sarcoma.
Internal Medicine Journal; Chatterton S, Helou J et. al.

Jun 20th, 2022 - Myeloid sarcoma (MS), also termed 'chloroma' or 'granulocytic sarcoma', is a tumour mass consisting of myeloid blasts occurring at an anatomical site other than the bone marrow. MS occurs in up to 8% of patients with acute myeloid leukaemia. While...

Identification of RCC1- LCK as a novel fusion gene in pediatric erythroid sarcoma.
Pediatric Blood & Cancer; Oya S, Osone S et. al.

Jun 18th, 2022 - Erythroid sarcoma is a very rare subtype of myeloid sarcoma with undetermined biological features. Here, we present an infant with a multifocal erythroid sarcoma, diagnosed because the tumor cells were positive for glycophorin A. After acute myelo...

The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia pres...
Medicine Gao L, Xu Y et. al.

May 28th, 2022 - Isolated myeloid sarcoma (MS) is characterized by the rapid proliferation of myeloblasts of acute myeloid leukemia (AML), without any blood or bone marrow involvement. This disease can manifest with extramedullary organ involvement, such as the sk...

Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation in...
Neoplasia (New York, N.Y.); Fu JF, Wen CJ et. al.

May 3rd, 2022 - The molecular mechanism of myeloid sarcoma (MS) formation remains nuclear. Our clinical and mouse model findings from a previous study revealed that cooperation of KMT2A (MLL) translocation (MLL-t) with activating N-/K-RAS mutations promoted MS fo...

Testicular myeloid sarcoma: a relapse of acute myeloid leukaemia after allogeneic perip...
BMJ Case Reports; Alam S, Palaniyandy V et. al.

Mar 20th, 2022 - Myeloid sarcoma is an uncommon pathological diagnosis of proliferation of blasts of one or more of the myeloid lineages in regions other than the blood and bone marrow. Myeloid sarcoma of the testis after allogeneic bone marrow stem cell transplan...

see more →

News  5 results

A Forum for Ideas, A Forum for Hope

Feb 21st, 2016 - OncLive Chairman, Mike Hennessy It was truly heartening to see Contemporary Radiation Oncology (CRO) proudly represented by its Editor-in-Chief, Stephen E. Finkelstein, MD, at this year’s Fiesta Bowl. Dr. Finkelstein participated in the cancer awa...

Study confirms IDH2 as therapeutic target in AML, MDS
Erilyn Riley

Dec 18th, 2014 - ASH attendees gather in the Moscone Center SAN FRANCISCO—The first-in-human study of AG-221 has confirmed IDH2 as a therapeutic target in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), according to investigators. From the first.

What Is Your Diagnosis? Granulocytic Sarcoma
Andrés Tirado-Sánchez, MD, MSc, Melva Equihua-Velázquez, MD

Aug 7th, 2014 - A 24-year-old man presented with a 5-cm asymptomatic, indurated, well-defined nodule with a violaceous center surrounded by a greenish halo on the lower back of 3 months’ duration, along with lymphadenopathy. There was no history of trauma, weight.

CNS involvement doesn’t affect survival after allo-SCT
Jen Smith

Mar 5th, 2014 - GRAPEVINE, TEXAS—Results of a large, retrospective study suggest that allogeneic stem cell transplant (allo-SCT) can overcome the poor prognosis associated with central nervous system (CNS) involvement in acute myeloid leukemia (AML). By analyzing.

Leukemia cutis
Christos Tziotzios, BA, MA, MB, BChir (Cantab), Areti Makrygeorgou, MD

Apr 1st, 2011 - Figure 1. A 72-year-old woman presents with a 3-week history of diarrhea, pyrexia, and a florid but asymptomatic skin eruption consisting of infiltrated erythematous papules and nodules that coalesce into large plaques ( Figures 1 and 2).

see more →